Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout ...
The FDA proposed excluding the active ingredients in popular obesity and diabetes drugs from a list of substances that can be ...
Most of the infant formula in the U.S. is safe, but experts and health officials say regulators can take steps to make the ...
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.
WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...
Imagine standing on a vast, dark plain. Without light, you cannot see dips and rolls in the grass or make out hills and valleys. Even if there’s a city off in the distance to your right, it does ...
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of ...
A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family ...
Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, ...
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
Elevance Health is blocking the deposition of Peter Haytaian, an outgoing executive who previously oversaw the health insurer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results